Loncastuximab tesirine 10mg powder for solution for infusion vials

in short Loncastuximab tesirine 10mg inf vials

SNOMED code
42534611000001105
Active compound
Loncastuximab tesirine
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Loncastuximab tesirine — 10 mg based on ingredient substance
Form & Route
solutioninfusion.intravenous
Powder for solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Zynlonta 10mg powder for concentrate for solution for infusion vials (Swedish Orphan Biovitrum Ltd)

in short Zynlonta 10mg pdr for concentrate for inf vials

Zynlonta 10mg powder for concentrate for solution for infusion vials

SNOMED code
42526711000001107
Supplier
Swedish Orphan Biovitrum Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Zynlonta 10mg powder for concentrate for solution for infusion vials (Swedish Orphan Biovitrum Ltd) 1 vial
42526811000001104   ref. pack
💯 Available

Legal category: POM
7350031444056
7350031444049
NHS Indicative Price
£15,200
• Hospital
  • • Prescription Charges

Reference packs

Loncastuximab tesirine 10mg powder for solution for infusion vials 1 vial
SNOMED code
42526611000001103
Quantity and unit
1 vial
Packs